45 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Helicobacter Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: 10 day sequential therapy (Esomeprazole, amoxicillin, clarithromycin, metronidazole);   Procedure: 7 day tailored therapy based on antimicrobial susceptibility testing;   Drug: PPI based triple therapy [Esomeprazole, amoxicillin, clarithromycin];   Drug: bismuth quadruple therapy [Esomeprazole, Tri potassium dicitrate bismuthate, Metronidazole, Tetracycline];   Drug: moxifloxacin triple therapy [Esomeprazole, Moxifloxacin, Amoxicillin]
2 Unknown  Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: Standard Triple Therapy;   Drug: Sequential Therapy
3 Unknown  Comparison of 7-Day and 14-Day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
Condition: Helicobacter Infection
Interventions: Drug: pantoprazole;   Drug: bismuth;   Drug: metronidazole;   Drug: tetracycline
4 Recruiting The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Procedure: H. pylori culture and antimicrobial susceptibility testing;   Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor);   Drug: Metronidazole;   Drug: Tetracycline;   Drug: tripotassium dicitrate bismuthate;   Drug: 7 days tailored therapy Proton Pump Inhibitor;   Drug: Moxifloxacin;   Drug: Amoxicillin
5 Recruiting Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
Condition: Helicobacter Infections
Intervention: Drug: Ilaprazole + Amoxicillin
6 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
7 Not yet recruiting Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
Condition: Helicobacter Infections
Interventions: Procedure: Gastroscopy;   Device: EndoFaster test;   Other: Clo test;   Other: Faecal Helicobacter pylori antigen
8 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
9 Unknown  Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Conditions: Parkinson's Disease;   Helicobacter Infections;   Motor Fluctuations
Interventions: Drug: clartihromycin, amoxicillin, and omeprazole;   Drug: placebo
10 Recruiting Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
Condition: Helicobacter Infections
Interventions: Drug: Noltec tab. 10mg;   Drug: Chongkundang Amoxicillin Cap. 500mg;   Drug: Cravit Tab. 500mg
11 Unknown  Immediate Detection of Helicobacter Infection With a New Electrochemical System.
Condition: H. Pylori Infection
Interventions: Device: Electrochemical H. pylori detection method;   Device: IHC;   Device: C13-urea breath test;   Device: HUT
12 Unknown  14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication
Condition: Helicobacter Pylori Infection
Intervention: Drug: PPI, amoxicillin, metronidazole and clarithromycin
13 Recruiting Epidemiology of Helicobacter Pylori Infection Among Shanghai Children
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Intervention:
14 Recruiting Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Reverse hybrid therapy;   Drug: Standard triple therapy
15 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Intervention: Drug: 10-day bismuth-based quadruple therapy
16 Unknown  Antimicrobial Susceptibility for Helicobacter Pylori Eradication
Condition: Helicobacter Pylori Infection
Intervention: Other: OCA 10
17 Recruiting Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: N-acetylcysteine + PPI-amoxicillin-clarithromycin;   Drug: PPI-amoxicillin-clarithromycin
18 Not yet recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
19 Recruiting Helicobacter Pylori Eradication Study in Parkinson's Disease
Conditions: Parkinson's Disease;   Helicobacter Pylori Infection
Interventions: Drug: Helicobacter pylori eradication therapy;   Drug: Placebo
20 Recruiting Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: triple, quadruple, non-bismuth quadruple therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years